Civic AI
Procurement intelligence
Federal contract award
ORAL BROAD SPECTRUM ANTIVIRAL TLR7
PRIMMUNE THERAPEUTICS, INC. · Department of Defense
- Value
- $11,211,689
- Start
- Jan 30, 2024
- End
- Aug 31, 2026
- Action date
- Jan 22, 2026
- PIID
- HDTRA124C0014
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CARLSBAD, CA
- Award type
- DEFINITIVE CONTRACT
Description
ORAL BROAD SPECTRUM ANTIVIRAL TLR7
Need modifications, related awards, and vendor peers? Open the full award workspace.